Envista Holdings (NVST) Net Income towards Common Stockholders (2018 - 2026)
Envista Holdings' (NVST) quarterly Net Income towards Common Stockholders came in at $38.7 million in Q2 2026, up 115.0% year-on-year from $18.0 million in Q2 2025, and up 17.63% quarter-over-quarter from $32.9 million in Q4 2025.
Envista Holdings (NVST) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends
Envista Holdings' Net Income towards Common Stockholders history runs 8 years deep, the most recent figure standing at $38.7 million for Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 115.0% year-over-year to $38.7 million in Q2 2026; TTM through Apr 2026 was $67.7 million, a 106.02% increase from a year earlier, with the FY2025 full-year figure at $47.0 million, changed N/A from the prior year.
- Net Income towards Common Stockholders rose to $38.7 million in Q2 2026 per NVST's latest filing, from $32.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $38.7 million in Q2 2026 and bottomed at -$1.2 billion in Q2 2024.
- The 4-year median for Net Income towards Common Stockholders is $6.4 million (2022), against an average of -$85.6 million.
- Biggest YoY gain for Net Income towards Common Stockholders was 2641.67% in 2025; the steepest drop was 469.51% in 2025.
- Year by year, Net Income towards Common Stockholders stood at -$2.0 million in 2022, then surged by 160.0% to $1.2 million in 2024, then jumped by 2641.67% to $32.9 million in 2025, then grew by 17.63% to $38.7 million in 2026.
- Per Business Quant, the three latest NVST Net Income towards Common Stockholders figures stand at $38.7 million (Q2 2026), $32.9 million (Q4 2025), and -$30.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Envista Holdings | 4.36 Bn | 3.28 Bn | 390.10 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 38.70 Mn |
| Dec 31, 2025 | 32.90 Mn |
| Sep 26, 2025 | -30.30 Mn |
| Jun 27, 2025 | 26.40 Mn |
| Mar 28, 2025 | 18.00 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 27, 2024 | 8.20 Mn |
| Jun 28, 2024 | -1.15 Bn |
| Mar 29, 2024 | 23.60 Mn |
| Sep 30, 2022 | -2.00 Mn |
| Jul 1, 2022 | 2.60 Mn |
| Apr 1, 2022 | 4.50 Mn |
| Dec 31, 2021 | 43.30 Mn |
| Oct 1, 2021 | 12.70 Mn |
| Jul 2, 2021 | 11.10 Mn |
| Apr 2, 2021 | 9.90 Mn |
| Dec 31, 2020 | 17.30 Mn |
| Oct 2, 2020 | 12.00 Mn |
| Jul 3, 2020 | -93.50 Mn |
| Apr 3, 2020 | -17.20 Mn |